Tolergyx

📍 Clermont-Ferrand, France🗓 Founded 2025👥 5 employees💰 Last funded Jul 2026
Biotechnology Research
LinkedIn
Tolergyx is a French biotech developing a gastrointestinal immunomodulation platform for the treatment of food allergies. Our approach is rooted in allergy and immunology, leveraging oral immunotherapeutic strategies designed to modulate immune responses at the gut level, with a strong focus on clinical translatability, regulatory robustness, and industrial scalability.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in Tolergyx?
Tolergyx has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Tolergyx last raise funding?
The most recent investment in Tolergyx recorded on gritt.io was in July 2026.
When was Tolergyx founded?
Tolergyx was founded in 2025.
What industry is Tolergyx in?
Tolergyx operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tolergyx based?
Tolergyx is headquartered in Clermont-Ferrand, France.